TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Pres. Bill Clinton to Serve as Honorary Chair Of NBCC’s Breast Cancer Deadline 2020 November 16, 2012
TCL Archive Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial. May 25, 2007